Identification of novel mPGES-1 inhibitors through screening of a chemical library
- PMID: 23147075
- DOI: 10.1016/j.bmcl.2012.10.085
Identification of novel mPGES-1 inhibitors through screening of a chemical library
Abstract
Human microsomal prostaglandin E synthase-1 (mPGES-1) is an emerging drug target for inflammatory disorders and cancer suppression. Therefore, it is crucially important to discover mPGES-1 inhibitors with novel structural scaffolds for the development of anti-inflammatory drugs. Here, we report the mPGES-1 inhibitors identified through screening of a chemical library. Initial screening of 1841 compounds out of 200,000 in a master library resulted in 9 primary hits. From the master library, 387 compounds that share the scaffold structure with the 9 primary hit compounds were selected, of which 3 compounds showed strong inhibitory activity against mPGES-1 having IC(50) values of 1-3 μM. Notably, a derivative of sulfonylhydrazide, compound 3b, inhibited the LPS-induced PGE(2) production in RAW 264.7 cells. This compound showed novel scaffold structure compared to the known inhibitors of mPGES-1, suggesting that it could be further developed as a potent mPGES-1 inhibitor.
Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.Bioorg Med Chem. 2012 Aug 15;20(16):5012-6. doi: 10.1016/j.bmc.2012.06.032. Epub 2012 Jun 23. Bioorg Med Chem. 2012. PMID: 22795900
-
Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid.Bioorg Med Chem Lett. 2013 Jan 1;23(1):75-80. doi: 10.1016/j.bmcl.2012.11.019. Epub 2012 Nov 15. Bioorg Med Chem Lett. 2013. PMID: 23218602
-
Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.Biochem Pharmacol. 2010 Apr 1;79(7):974-81. doi: 10.1016/j.bcp.2009.11.011. Epub 2009 Nov 27. Biochem Pharmacol. 2010. PMID: 19925781
-
Identification and development of mPGES-1 inhibitors: where we are at?Future Med Chem. 2011 Nov;3(15):1909-34. doi: 10.4155/fmc.11.136. Future Med Chem. 2011. PMID: 22023034 Free PMC article. Review.
-
Characterization of microsomal prostaglandin E synthase 1 inhibitors.Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):64-9. doi: 10.1111/bcpt.12162. Epub 2013 Nov 11. Basic Clin Pharmacol Toxicol. 2014. PMID: 24138533 Review.
Cited by
-
The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders.Exp Biol Med (Maywood). 2023 May;248(9):811-819. doi: 10.1177/15353702231179926. Epub 2023 Jul 29. Exp Biol Med (Maywood). 2023. PMID: 37515545 Free PMC article. Review.
-
Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.Am J Transl Res. 2021 Jan 15;13(1):391-419. eCollection 2021. Am J Transl Res. 2021. PMID: 33527033 Free PMC article.
-
Discovery of novel, non-acidic mPGES-1 inhibitors by virtual screening with a multistep protocol.Bioorg Med Chem. 2015 Aug 1;23(15):4839-4845. doi: 10.1016/j.bmc.2015.05.045. Epub 2015 Jun 1. Bioorg Med Chem. 2015. PMID: 26088337 Free PMC article.
-
Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.Mol Divers. 2017 Aug;21(3):661-675. doi: 10.1007/s11030-017-9743-x. Epub 2017 May 8. Mol Divers. 2017. PMID: 28484935
-
Inducible Prostaglandin E Synthase as a Pharmacological Target for Ischemic Stroke.Neurotherapeutics. 2022 Jan;19(1):366-385. doi: 10.1007/s13311-022-01191-1. Epub 2022 Jan 31. Neurotherapeutics. 2022. PMID: 35099767 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information